ITGAM and neoplasm: It has been shown that CD11b+ Gr1+ myeloid cells, which include neutrophils, macrophages and myeloid-derived suppressor cells, promote tumour progression independent of the adaptive immune system, and that these cells render tumours refractory to angiogenic blockade by VEGF antibodies 18.